+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Reproductive Technologies Market - Global Forecast 2026-2032- Product Image
Human Reproductive Technologies Market - Global Forecast 2026-2032- Product Image
New

Human Reproductive Technologies Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887220
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human reproductive technologies market is undergoing significant transformation, propelled by scientific advancements and evolving patient needs. Senior decision-makers face a rapidly changing environment marked by complex regulatory considerations and increasing expectations for patient-centered care. Navigating these shifts requires strategic insight and systematic adaptation across the entire ecosystem.

Market Snapshot: Human Reproductive Technologies Market Size and Growth

The Human Reproductive Technologies Market expanded from USD 33.97 billion in 2025 to USD 36.26 billion in 2026. Sustained by an anticipated CAGR of 6.87%, market value is projected to reach USD 54.09 billion by 2032. This upward trend reflects increased adoption of laboratory innovations and growing attention to patient-centric solutions, as organizations address heightened demand for fertility and genetics-based healthcare services. Market players face ongoing shifts shaped by regulatory updates, global collaboration, and the rising complexity of reproductive medical practice.

Scope & Segmentation of the Human Reproductive Technologies Market

This comprehensive report delivers granular segmentation, guiding leaders in aligning resources and service models across the reproductive healthcare continuum. The following segments define the landscape of the human reproductive technologies market:

  • Therapy Types: Includes assisted reproductive technologies such as in vitro fertilization, gamete intrafallopian transfer, intracytoplasmic sperm injection, intrauterine insemination, and zygote intrafallopian transfer, reflecting the breadth of clinical interventions supporting patient journeys.
  • Applications: Covers fertility preservation approaches—embryo, oocyte, and sperm cryopreservation—as well as genetic testing focused on aneuploidy, monogenic, and structural rearrangements. Treatments for infertility are central, addressing a wide spectrum of patient cases.
  • Drug Regimens: Encompasses the use of GnRH analogues, gonadotropins, human chorionic gonadotropin, and progesterone. These pharmaceutical protocols underpin ovarian stimulation and endometrial preparation, directly impacting cycle outcomes and protocol personalization.
  • Provider Models: Recognizes fertility clinics, hospitals, and research institutes as key service providers. These organizations implement differentiated care delivery, research strategies, and meet various accreditation requirements, supporting operational and scientific excellence.
  • End-User Groups: Serves heterosexual couples, LGBTQ couples, and single parents. Each group presents unique needs for counseling, donor coordination, and legal guidance, highlighting the importance of inclusive, flexible care frameworks.
  • Regional Coverage: Provides analysis across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region demonstrates distinct regulatory environments, technology adoption rates, and patient access challenges, requiring locally tailored strategies.

Key Takeaways for Strategic Decision-Making

  • Collaboration among clinicians, embryologists, and geneticists is critical for translating laboratory advances into effective, individualized reproductive healthcare.
  • Broad deployment of digital tools, precision genetic testing, and advanced cryopreservation enables more tailored protocols, efficient laboratory operations, and better patient access.
  • Strengthening supply chains through robust supplier qualification and data-driven procurement helps manage risk as reliance on specialized consumables and regulatory compliance grows.
  • Service models adapt to include a broader range of patient demographics, which calls for inclusive communication and culturally responsive counseling at every touchpoint.
  • Quality assurance initiatives, system interoperability, and transparent outcome reporting are central to reinforcing regulatory trust and supporting clinical confidence in service design.
  • Investment in emerging technologies and workforce upskilling positions market participants to adapt to evolving standards and expectations.

Tariff Impact on Procurement and Operations

Changing tariffs and international trade measures are elevating procurement and manufacturing costs for specialized materials and equipment in reproductive medicine. Providers benefit from adopting multi-vendor validation and contingency sourcing to limit operational risks associated with supply chain disruptions. Manufacturers may respond with adjustments in their sourcing or production locations, influencing both the predictability of equipment supply and the timeline for clinical and R&D adoption. Proactive governance, ongoing quality validation, and stakeholder consultation are crucial for maintaining operational resilience and supporting uninterrupted patient access as tariff landscapes evolve.

Methodology & Data Sources

This report is underpinned by primary interviews with clinicians, laboratory directors, procurement specialists, and regulatory authorities. Findings are further validated through a secondary review of literature, technical standards, and industry guidelines. Expert-driven triangulation ensures the highest accuracy and relevance for senior leaders across the sector.

Why This Report Matters

  • Enables benchmarking of technology adoption and clinical workflow design, aligning operations with current best practices in reproductive healthcare.
  • Identifies actionable procurement, compliance, and operational strategies for sustaining service delivery, managing supply chain risk, and improving patient engagement.
  • Empowers leaders to make informed investments and partnership choices in response to evolving market, regulatory, and demographic dynamics.

Conclusion

Continued progress in the human reproductive technologies market relies on modernizing laboratories, widening patient access, and enhancing operational agility. Adapting flexible, patient-focused strategies enables organizations to thrive within this increasingly sophisticated sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Human Reproductive Technologies Market, by Assisted Reproductive Technology Type
8.1. Gamete Intrafallopian Transfer
8.2. In Vitro Fertilization
8.2.1. Fresh Embryo Transfer
8.2.2. Frozen Embryo Transfer
8.3. Intracytoplasmic Sperm Injection
8.4. Intrauterine Insemination
8.5. Zygote Intrafallopian Transfer
9. Human Reproductive Technologies Market, by Fertility Drug Type
9.1. GnRH Analogue
9.2. Gonadotropin
9.3. Human Chorionic Gonadotropin
9.4. Progesterone
10. Human Reproductive Technologies Market, by Service Provider
10.1. Fertility Clinic
10.2. Hospital
10.3. Research Institute
11. Human Reproductive Technologies Market, by Application
11.1. Fertility Preservation
11.1.1. Embryo Cryopreservation
11.1.2. Oocyte Cryopreservation
11.1.3. Sperm Cryopreservation
11.2. Genetic Testing
11.2.1. PGT A
11.2.2. PGT M
11.2.3. PGT SR
11.3. Infertility Treatment
12. Human Reproductive Technologies Market, by End User
12.1. Heterosexual Couple
12.2. LGBTQ Couple
12.3. Single Parent
13. Human Reproductive Technologies Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Human Reproductive Technologies Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Human Reproductive Technologies Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Human Reproductive Technologies Market
17. China Human Reproductive Technologies Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Cook Medical LLC
18.6. CooperSurgical, Inc.
18.7. Ferring Pharmaceuticals A/S
18.8. Illumina, Inc.
18.9. Laboratory Corporation of America Holdings
18.10. Merck KGaA
18.11. Natera, Inc.
18.12. Pfizer Inc.
18.13. Pride Angel
18.14. Progyny, Inc.
18.15. Sandoz International GmbH
18.16. Sun Pharmaceutical Industries Ltd.
18.17. Teva Pharmaceutical Industries Ltd.
18.18. Thermo Fisher Scientific Inc.
18.19. V Conceive
18.20. Vitrolab AB
18.21. Vitrolife AB
18.22. Voxtur Bio Ltd.
List of Figures
FIGURE 1. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 133. EUROPE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 146. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 147. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 148. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 150. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 151. AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 165. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 167. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 169. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 170. ASEAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 174. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 175. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 176. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 178. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 179. GCC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 192. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 193. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 194. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 196. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 197. BRICS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 201. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 202. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 203. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 205. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 206. G7 HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 209. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 210. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 212. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 214. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 215. NATO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 228. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 229. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 230. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
TABLE 231. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2032 (USD MILLION)
TABLE 233. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 234. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Human Reproductive Technologies market report include:
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Ferring Pharmaceuticals A/S
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Natera, Inc.
  • Pfizer Inc.
  • Pride Angel
  • Progyny, Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • V Conceive
  • Vitrolab AB
  • Vitrolife AB
  • Voxtur Bio Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 54.09 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Assisted Reproductive Technology Market - Global Forecast 2026-2032 - Product Image

Assisted Reproductive Technology Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Assisted Reproductive Technology Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Assisted Reproductive Technology Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Assisted Reproductive Technology Market Report and Forecast 2025-2034 - Product Image

Assisted Reproductive Technology Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Assisted Reproductive Technology Market Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts - Product Image

Assisted Reproductive Technology Market Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts

  • Report
  • 200 Pages
  • Global
From
Assisted Reproductive Technology Market - Product Image

Assisted Reproductive Technology Market

  • Report
  • 92 Pages
  • Global
From

About the Human Reproductive Technologies Market

The Human Reproductive Technologies market is a subset of the Sexual and Reproductive Health Drugs market. It includes products and services related to fertility, contraception, and assisted reproductive technologies. These technologies are used to help individuals and couples conceive, prevent pregnancy, and manage reproductive health. They include fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, as well as contraception methods such as birth control pills, intrauterine devices (IUDs), and male and female condoms. Assisted reproductive technologies include egg and sperm donation, surrogacy, and preimplantation genetic diagnosis (PGD). Some companies in the Human Reproductive Technologies market include Ferring Pharmaceuticals, Merck, Bayer, and CooperSurgical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.